MedTrace Logo

Plasma S-adenosylhomocysteine Levels and Endothelial Dysfunction

NCT03345927 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2021-03-17

No results posted yet for this study

Summary

To investigate the relationship betweeen plasma S-adenosylhomocysteine (SAH) levels and endothelial dysfunction, we plan to enroll approximately 150 patients with high risk of cardiovascualr disease,who will be measaured the flow-mediated dilation by B-ultrasound, and then measaured the plasma levels of methionine metabolites, such as SAH, SAM, and analyze the association.

Conditions

Interventions

OTHER

no intervention

no intervention

Sponsors & Collaborators

  • Peking University Shenzhen Hospital

    collaborator OTHER

  • Shenzhen Center for Disease Control and Prevention

    lead OTHER_GOV

Principal Investigators

  • Yuebin Ke, Dr. · Shenzhen CDC

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-04
Primary Completion
2018-03-30
Completion
2018-04-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03345927 on ClinicalTrials.gov